F. Reesink

发表

Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies

R. Boellaard, P. D. De Deyn, D. Peretti, 2019, PloS one.

Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease

R. Boellaard, P. D. De Deyn, D. Peretti, 2019, EJNMMI Research.

Diagnostic Performance of Regional Cerebral Blood Flow Images Derived from Dynamic PIB Scans in Alzheimer’s Disease

R. Boellaard, D. Peretti, F. Reesink, 2018 .

Nuclear Imaging in Frontotemporal Dementia

F. Reesink, R. Dierckx, P. Deyn, 2020, PET and SPECT in Neurology.

Uptake and effectiveness of a tailor-made online lifestyle programme targeting modifiable risk factors for dementia among middle-aged descendants of people with recently diagnosed dementia: study protocol of a cluster randomised controlled trial (Demin study)

A. D. de Winter, A. Abu-Hanna, N. Smidt, 2020, BMJ Open.

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease

W. M. van der Flier, F. Verhey, P. D. De Deyn, 2017, Journal of Alzheimer's disease : JAD.

Emotion Recognition and Traffic-Related Risk-Taking Behavior in Patients with Neurodegenerative Diseases

E. D. de Haan, F. Reesink, J. Spikman, 2020, Journal of the International Neuropsychological Society.

University of Groningen Optimization of the k(2)' Parameter Estimation for the Pharmacokinetic Modeling of Dynamic PIB PET Scans Using SRTM2 Peretti,

R. Boellaard, D. Peretti, F. Reesink, 2019 .

Optimization of the k2′ Parameter Estimation for the Pharmacokinetic Modeling of Dynamic PIB PET Scans Using SRTM2

R. Boellaard, P. D. De Deyn, D. Peretti, 2019, Front. Phys..

Alzheimer’s disease pattern derived from relative cerebral flow as an alternative for the metabolic pattern using SSM/PCA

R. Boellaard, P. D. De Deyn, R. Renken, 2022, EJNMMI Research.

Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies

R. Boellaard, P. D. De Deyn, D. Peretti, 2019, PloS one.

FDG-PET combined with learning vector quantization allows classification of neurodegenerative diseases and reveals the trajectory of idiopathic REM sleep behavior disorder

Michael Biehl, W. Oertel, R. Renken, 2022, Comput. Methods Programs Biomed..

Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease

M. J. Brinkman, E. Pekkonen, F. Scheperjans, 2022, npj Parkinson's Disease.

Knowledge, Beliefs and Attitudes Towards Dementia and Dementia Risk Reduction Among Descendants of People with Dementia: A Qualitative Study Using Focus Group Discussions

P. Deyn, A. Abu-Hanna, N. Smidt, 2021 .

Planning in amnestic mild cognitive impairment: an fMRI study

P. Deyn, A. Aleman, F. Reesink, 2021, Experimental Gerontology.

Widespread white matter aberration is associated with the severity of apathy in amnestic Mild Cognitive Impairment: Tract-based spatial statistics analysis

S. Martens, A. Aleman, F. Reesink, 2021, NeuroImage: Clinical.

Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis

R. Boellaard, R. Renken, D. Peretti, 2021, NeuroImage: Clinical.

Amyloid burden quantification depends on PET and MR image processing methodology

R. Boellaard, A. Willemsen, D. Vállez García, 2021, PloS one.

Lower Choline and Myo-Inositol in Temporo-Parietal Cortex Is Associated With Apathy in Amnestic MCI

Sander Martens, Shankar Tumati, Peter P. De Deyn, 2018, Front. Aging Neurosci..

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

W. M. van der Flier, P. Scheltens, Y. Pijnenburg, 2012, Neurology.

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder

Remco J. Renken, Sebastiaan Overeem, Karl Kesper, 2017, Movement disorders : official journal of the Movement Disorder Society.

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson’s disease patients for the identification and validation of biomarkers for Parkinson’s disease subtypes, progression and pathophysiology

T. van Laar, B. van Harten, A. Bartels, 2020, BMC Neurology.

Crossed Cerebellar Diaschisis in Alzheimer's Disease.

R. Boellaard, A. Willemsen, D. Peretti, 2018, Current Alzheimer research.

Knowledge, health beliefs and attitudes towards dementia and dementia risk reduction among descendants of people with dementia: a qualitative study using focus group discussions

A. Abu-Hanna, S. D. de Rooij, F. Reesink, 2021, BMC Public Health.

CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease.

W. M. van der Flier, H. Berendse, P. Scheltens, 2010, Journal of Alzheimer's disease : JAD.

Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia

P. Deyn, W. Flier, H. Koek, 2021, Neurobiology of Aging.

Temporal dynamics of depression, cognitive performance and sleep in older persons with depressive symptoms and cognitive impairments: a series of eight single-subject studies

F. Reesink, R. O. Oude Voshaar, S. Zuidema, 2021, International Psychogeriatrics.

Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies

D. Perani, L. Ferini-Strambi, A. Padovani, 2023, NeuroImage: Clinical.

Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies

D. Perani, L. Ferini-Strambi, A. Padovani, 2023, NeuroImage: Clinical.

Widespread white matter aberration is associated with the severity of apathy in amnestic Mild Cognitive Impairment

F. Reesink, J. Marsman, S. Tumati, 2021 .